BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock Short Interest Falls 60.9%

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large decrease in short interest during the month of September. As of September 30th, there was short interest totaling 32,798 shares, a decrease of 60.9% from the September 15th total of 83,940 shares. Based on an average daily trading volume, of 128,882 shares, the short-interest ratio is currently 0.3 days.

BlackRock Health Sciences Term Trust Stock Down 1.0%

BlackRock Health Sciences Term Trust stock traded down $0.17 during trading hours on Tuesday, hitting $16.25. The company had a trading volume of 49,471 shares, compared to its average volume of 201,705. The firm has a 50-day moving average of $16.56 and a 200 day moving average of $15.32. BlackRock Health Sciences Term Trust has a one year low of $13.70 and a one year high of $17.25.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, December 22nd. Stockholders of record on Friday, December 11th will be given a $0.11 dividend. The ex-dividend date of this dividend is Friday, December 11th. This represents a $1.32 annualized dividend and a dividend yield of 8.1%.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of large investors have recently made changes to their positions in the company. Saba Capital Management L.P. acquired a new stake in BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $10,907,000. Calamos Advisors LLC acquired a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at $740,000. Corient Private Wealth LP acquired a new position in BlackRock Health Sciences Term Trust in the 2nd quarter valued at $467,000. Lazard Asset Management LLC grew its holdings in BlackRock Health Sciences Term Trust by 64.2% in the 1st quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock valued at $8,926,000 after buying an additional 243,054 shares in the last quarter. Finally, Rivernorth Capital Management LLC increased its position in BlackRock Health Sciences Term Trust by 24.8% during the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock worth $11,620,000 after buying an additional 160,629 shares during the period.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a publicly traded closed-end investment fund managed by BlackRock Advisors, LLC. The fund seeks to provide total returns through a combination of current income and long-term capital appreciation by investing primarily in companies involved in the health sciences sector.

BMEZ’s investment universe includes businesses in areas such as biotechnology, pharmaceuticals, medical devices, health-care services, and life-sciences tools and equipment.